vs
GLAUKOS Corp（GKOS）与VIRTUS INVESTMENT PARTNERS, INC.（VRTS）财务数据对比。点击上方公司名可切换其他公司
VIRTUS INVESTMENT PARTNERS, INC.的季度营收约是GLAUKOS Corp的1.3倍（$199.5M vs $150.6M），GLAUKOS Corp净利率更高（6.2% vs 3.6%，领先2.7%），GLAUKOS Corp同比增速更快（41.2% vs -4.1%），过去两年GLAUKOS Corp的营收复合增速更高（25.4% vs -5.7%）
Glaukos Corp是一家专注于眼科领域的医疗科技企业，开发并商业化用于治疗青光眼、角膜疾病等眼部病症的微创手术器械、处方药物及消费级产品，主要市场覆盖北美、欧洲及亚太地区，为全球医院、眼科诊所及患者提供服务。
Virtus Investment Partners是一家美国多管理人资产管理企业，旗下汇集多家具备独立投资流程与自有品牌的关联投资管理人，同时也提供非关联子投资顾问服务，为客户提供多元化的资产管理解决方案。
GKOS vs VRTS — 直观对比
营收规模更大
VRTS
是对方的1.3倍
$150.6M
营收增速更快
GKOS
高出45.2%
-4.1%
净利率更高
GKOS
高出2.7%
3.6%
两年增速更快
GKOS
近两年复合增速
-5.7%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $150.6M | $199.5M |
| 净利润 | $9.4M | $7.1M |
| 毛利率 | 77.9% | — |
| 营业利润率 | 9.0% | 7.7% |
| 净利率 | 6.2% | 3.6% |
| 营收同比 | 41.2% | -4.1% |
| 净利润同比 | — | -78.1% |
| 每股收益（稀释后） | — | $1.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GKOSVRTS
| Q1 26 | $150.6M | $199.5M | ||
| Q4 25 | $143.1M | $208.0M | ||
| Q3 25 | $133.5M | $216.4M | ||
| Q2 25 | $124.1M | $210.5M | ||
| Q1 25 | $106.7M | $217.9M | ||
| Q4 24 | $105.5M | $233.5M | ||
| Q3 24 | $96.7M | $227.0M | ||
| Q2 24 | $95.7M | $224.4M |
净利润GKOSVRTS
| Q1 26 | $9.4M | $7.1M | ||
| Q4 25 | $-133.7M | $33.9M | ||
| Q3 25 | $-16.2M | $31.3M | ||
| Q2 25 | $-19.7M | $42.7M | ||
| Q1 25 | $-18.1M | $28.1M | ||
| Q4 24 | $-33.6M | $39.5M | ||
| Q3 24 | $-21.4M | $49.1M | ||
| Q2 24 | $-50.5M | $26.0M |
毛利率GKOSVRTS
| Q1 26 | 77.9% | — | ||
| Q4 25 | -1.1% | — | ||
| Q3 25 | 78.4% | — | ||
| Q2 25 | 78.3% | — | ||
| Q1 25 | 77.2% | — | ||
| Q4 24 | 72.9% | — | ||
| Q3 24 | 76.6% | — | ||
| Q2 24 | 76.4% | — |
营业利润率GKOSVRTS
| Q1 26 | 9.0% | 7.7% | ||
| Q4 25 | -97.7% | 19.1% | ||
| Q3 25 | -12.3% | 21.7% | ||
| Q2 25 | -18.3% | 21.5% | ||
| Q1 25 | -19.4% | 16.8% | ||
| Q4 24 | -27.2% | 21.7% | ||
| Q3 24 | -25.5% | 24.3% | ||
| Q2 24 | -31.3% | 19.7% |
净利率GKOSVRTS
| Q1 26 | 6.2% | 3.6% | ||
| Q4 25 | -93.4% | 16.3% | ||
| Q3 25 | -12.2% | 14.5% | ||
| Q2 25 | -15.8% | 20.3% | ||
| Q1 25 | -17.0% | 12.9% | ||
| Q4 24 | -31.8% | 16.9% | ||
| Q3 24 | -22.1% | 21.6% | ||
| Q2 24 | -52.8% | 11.6% |
每股收益（稀释后）GKOSVRTS
| Q1 26 | — | $1.05 | ||
| Q4 25 | $-2.34 | $5.15 | ||
| Q3 25 | $-0.28 | $4.65 | ||
| Q2 25 | $-0.34 | $6.12 | ||
| Q1 25 | $-0.32 | $4.05 | ||
| Q4 24 | $-0.56 | $4.65 | ||
| Q3 24 | $-0.39 | $5.71 | ||
| Q2 24 | $-1.00 | $2.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $276.7M | $136.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $670.9M | $93.6B |
| 总资产 | $893.3M | — |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GKOSVRTS
| Q1 26 | $276.7M | $136.6M | ||
| Q4 25 | $90.8M | — | ||
| Q3 25 | $98.2M | — | ||
| Q2 25 | $100.8M | — | ||
| Q1 25 | $114.3M | — | ||
| Q4 24 | $169.6M | — | ||
| Q3 24 | $100.1M | — | ||
| Q2 24 | $68.1M | — |
总债务GKOSVRTS
| Q1 26 | — | — | ||
| Q4 25 | — | $390.0M | ||
| Q3 25 | — | $390.6M | ||
| Q2 25 | — | $231.3M | ||
| Q1 25 | — | $231.7M | ||
| Q4 24 | — | $232.1M | ||
| Q3 24 | — | $237.5M | ||
| Q2 24 | — | $247.6M |
股东权益GKOSVRTS
| Q1 26 | $670.9M | $93.6B | ||
| Q4 25 | $656.2M | $934.0M | ||
| Q3 25 | $769.5M | $918.7M | ||
| Q2 25 | $765.1M | $896.4M | ||
| Q1 25 | $764.0M | $893.7M | ||
| Q4 24 | $766.9M | $897.5M | ||
| Q3 24 | $668.5M | $889.0M | ||
| Q2 24 | $665.2M | $868.7M |
总资产GKOSVRTS
| Q1 26 | $893.3M | — | ||
| Q4 25 | $893.5M | $4.3B | ||
| Q3 25 | $999.4M | $3.9B | ||
| Q2 25 | $987.0M | $3.7B | ||
| Q1 25 | $966.2M | $3.7B | ||
| Q4 24 | $974.8M | $4.0B | ||
| Q3 24 | $926.5M | $3.6B | ||
| Q2 24 | $919.7M | $3.6B |
负债/权益比GKOSVRTS
| Q1 26 | — | — | ||
| Q4 25 | — | 0.42× | ||
| Q3 25 | — | 0.43× | ||
| Q2 25 | — | 0.26× | ||
| Q1 25 | — | 0.26× | ||
| Q4 24 | — | 0.26× | ||
| Q3 24 | — | 0.27× | ||
| Q2 24 | — | 0.29× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GKOS
暂无分部数据
VRTS
| Investment management fees | $169.1M | 85% |
| Administration and shareholder service fees | $17.3M | 9% |
| Distribution and service fees | $11.6M | 6% |
